回盛生物 (300871)
WUHAN HVSEN BIOTECHNOLOGY CO.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 20233.26
- Circulating A-Shares(W): 20233.26
- Earnings Per Share(RMB): 1.0134
- Net Assets Per Share(RMB): 10.4204
- Operating Revenue(W RMB): 125953.40
- Total Profit(W RMB): 21458.78
- Net Profit Attributable to Parent(W RMB): 18790.63
- Net Profit Growth Rate(%): 494.28
- Weighted Return on Equity(%): 10.3500
- Operating Cash Flow Per Share(RMB): 0.8970
- Undistributed Profit Per Share(RMB): 2.0932
- Capital Reserve Per Share(RMB): 7.1719
2. Main Business
The main business covers:
- Veterinary Drugs (including chemical preparations, APIs, and traditional Chinese medicine preparations)
- Feed and Additives
3. Company Basic Information
- Company Name: Wuhan Hvsen Biotechnology Co., Ltd.
- Listing Date: 2020-08-24
- Industry: Pharmaceutical Manufacturing
- Address: No. 1 Zhonghua Road, Wuchang District, Wuhan City, Hubei Province
- Website: www.whhsyy.com
- Company Profile：On November 15, 2016, all shareholders of the company signed the "Sponsor Agreement", agreeing to restructure Hvsen Co., Ltd. into a joint stock company based on the audited net assets as of August 31, 2016. According to the audit report issued by ZhongShen ZhongHuan, the audited net asset value of the company was 136.7539 million yuan, of which 80 million yuan was converted into the share capital of the joint stock company, and the remaining 56.7539 million yuan was included in the capital reserve. On December 10, 2016, ZhongShen ZhongHuan verified the above matters and issued the capital verification report. On December 23, 2016, Hvsen Biotechnology obtained the business license issued by the Hubei Provincial Administration for Industry and Commerce. On December 28, 2016, the Wuhan Municipal Bureau of Commerce issued the "Foreign-invested Enterprise Change Filing Receipt" for the above matters.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Wuhan Tongsheng Investment Co., Ltd. | General Legal Person | 8280.00 | 40.92 |
| 2 | Beijing Jiuzhou Wanli Investment Co., Ltd. | General Legal Person | 106.00 | 0.52 |
| 3 | Wuhan Hvsen Biotechnology Co., Ltd.-2023 Employee Stock Ownership Plan | Asset Management Plan | 98.14 | 0.49 |
| 4 | Wanjia CSI 2000 Index Enhanced Securities Investment Fund Class A | Fund | 0.84 | 0.00 |
5. Concept Sectors
- Innovative Drugs
- Synthetic Biology
- Pet Economy
- Margin Trading & Securities Lending
- High-Performance Stock
- ChiNext Quality
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information